Suppr超能文献

[丙泊酚用于心脏手术麻醉诱导与维持。人体药理学研究结果]

[Propofol for induction and maintenance of anesthesia during heart surgery. Results of pharmacological studies in man].

作者信息

Seitz W, Lübbe N, Schaps D, Haverich A, Kirchner E

机构信息

Zentrum Anaesthesiologie, Abteilung I, Medizinische Hochschule Hannover.

出版信息

Anaesthesist. 1991 Mar;40(3):145-52.

PMID:2035820
Abstract

Numerous reports have concluded that propofol is suitable for maintenance of anesthesia by continuous infusion. The aim of this study was to evaluate the use of propofol and fentanyl for coronary bypass surgery in patients with good left ventricular function. The effects of this anesthetic combination on quality of anesthesia, hemodynamic status, and endocrine and metabolic responses were assessed. Postoperative recovery and side effects were also noted. The effects were compared with those of a standard method using etomidate, midazolam, and fentanyl. METHODS. Twenty patients who presented for aortocoronary bypass surgery (NYHA class II-III) were randomly allocated to one of two groups: propofol-fentanyl (group A) or etomidate-midazolam-fentanyl (group B). In each patient the dosage of the drugs was adjusted to obtain the optimum responses during induction and maintenance. RESULTS. Propofol in combination with fentanyl diminished mean arterial pressure (-28.7%) and heart rate (-17.3%) when used for induction in patients with ischemic heart disease, even in low doses and with slow administration. In 5 of the 10 patients it was impossible to prevent a critical fall in coronary perfusion without active intervention. However, during maintenance anesthesia, stable circulatory parameters were obtained with both drug regimens. Clinical signs thought to reflect myocardial ischemia were not observed. In both groups reductions in basal and stimulated catecholamine secretion were demonstrated. Similarly, perioperative cortisol secretion was reduced with both techniques. Despite all the complicated metabolic inhibitory effects seen, preoperative hormonal levels were restored within 1 h of the end of anesthesia. The magnitude and duration of the metabolic changes were found to be related to the duration of surgery. There was no evidence of non-homogeneous tissue perfusion as assessed by increases in lactate concentration, cardiac ischemia, or liver dysfunction in any of the patients. There were no postoperative complications in either group, but the return of consciousness, adequate spontaneous ventilation, and psychomotor activity was more rapid in the propofol patients. CONCLUSION. In summary, it can be concluded that a propofol infusion technique positively enhances the recovery period after cardiac surgery and provides good control during anesthesia. However, the use of propofolfentanyl for induction of anesthesia in patients with limited coronary perfusion is not recommended because of its hypotensive effect.

摘要

众多报告得出结论,丙泊酚适用于持续输注维持麻醉。本研究的目的是评估丙泊酚和芬太尼在左心室功能良好的患者行冠状动脉搭桥手术中的应用。评估了这种麻醉组合对麻醉质量、血流动力学状态以及内分泌和代谢反应的影响。还记录了术后恢复情况和副作用。将这些效果与使用依托咪酯、咪达唑仑和芬太尼的标准方法的效果进行了比较。方法:20例拟行主动脉冠状动脉搭桥手术(纽约心脏协会II - III级)的患者被随机分为两组之一:丙泊酚 - 芬太尼组(A组)或依托咪酯 - 咪达唑仑 - 芬太尼组(B组)。在每位患者中,调整药物剂量以在诱导和维持期间获得最佳反应。结果:丙泊酚与芬太尼联合用于缺血性心脏病患者诱导时,即使低剂量且给药缓慢,平均动脉压仍下降(-28.7%),心率下降(-17.3%)。在10例患者中的5例中,若不进行积极干预,无法防止冠状动脉灌注的严重下降。然而,在维持麻醉期间,两种药物方案均获得了稳定的循环参数。未观察到被认为反映心肌缺血的临床体征。两组均显示基础和刺激后的儿茶酚胺分泌减少。同样,两种技术均使围手术期皮质醇分泌减少。尽管观察到所有复杂的代谢抑制作用,但麻醉结束后1小时内术前激素水平得以恢复。发现代谢变化的程度和持续时间与手术持续时间有关。在任何患者中,均未通过乳酸浓度升高、心肌缺血或肝功能障碍评估出组织灌注不均一的证据。两组均无术后并发症,但丙泊酚组患者意识恢复、自主通气充分和精神运动活动恢复更快。结论:总之,可以得出结论,丙泊酚输注技术确实可改善心脏手术后的恢复期,并在麻醉期间提供良好的控制。然而,由于其降压作用,不建议在冠状动脉灌注受限的患者中使用丙泊酚 - 芬太尼进行麻醉诱导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验